Evidence map›Paper›PMID 32765425›Full record

ReviewFrontiers in endocrinology2020

Neuroendocrine and Metabolic Effects of Low-Calorie and Non-Calorie Sweeteners.

Eleonora Moriconi, Alessandra Feraco, Vincenzo Marzolla, Marco Infante, Mauro Lombardo, Andrea Fabbri, Massimiliano Caprio

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Food sweeteners: Angels or clowns for human health?Current research in food science · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Eleonora MoriconiLaboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Rome, Italy.
Alessandra FeracoLaboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Rome, Italy.
Vincenzo MarzollaLaboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Rome, Italy.
Marco InfanteUnit of Endocrinology and Metabolic Diseases, Department of Systems Medicine, CTO A. Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
Mauro LombardoDepartment of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, Rome, Italy.
Andrea FabbriUnit of Endocrinology and Metabolic Diseases, Department of Systems Medicine, CTO A. Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
Massimiliano CaprioLaboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Rome, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico San RaffaeleCTO Andrea Alesini · ITSapienza University of Rome · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since excessive sugar consumption has been related to the development of chronic metabolic diseases prevalent in the western world, the use of sweeteners has gradually increased worldwide over the last few years. Although low- and non-calorie sweeteners may represent a valuable tool to reduce calorie intake and prevent weight gain, studies investigating the safety and efficacy of these compounds in the short- and long-term period are scarce and controversial. Therefore, future studies will need to elucidate the potential beneficial and/or detrimental effects of different types of sweeteners on metabolic health (energy balance, appetite, body weight, cardiometabolic risk factors) in healthy subjects and patients with diabetes, obesity and metabolic syndrome. In this regard, the impact of different sweeteners on central nervous system, gut hormones and gut microbiota is important, given the strong implications that changes in such systems may have for human health. The aim of this narrative review is to summarize the current evidence for the neuroendocrine and metabolic effects of sweeteners, as well as their impact on gut microbiota. Finally, we briefly discuss the advantages of the use of sweeteners in the context of very-low calorie ketogenic diets.

Indexed as

Energy IntakeEnergy MetabolismGastrointestinal MicrobiomeHumansNeurosecretory SystemsSweetening AgentsSweetening Agentsbody weightdiabetesmetabolic healthmicrobiotaobesitysafetysugarVLCKD

Identifiers

PMID32765425
PMCPMC7378387
OpenAlexW3042824376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.